Venous Thromboembolism and Pregnancy: Prevention and Treatment
- 1Division of Hematology, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
Abstract
Pregnancy-related venous thromboembolism (VTE) remains a leading cause of maternal morbidity and mortality. Physiologic changes in pregnancy, along with patient-specific and pregnancy-specific risk factors, increase this VTE risk. The prevention and treatment of pregnancy-related VTE is often complex and requires the careful consideration of variation in clinical guidelines, VTE risk profile, bleeding assessment, careful delivery planning and patient preference. The mainstay of treatment for an acute VTE in pregnancy is the use of low-molecular-weight heparin. In this review, we highlight three clinical cases to review clinical approaches to the prevention and treatment of VTE in pregnancy in these scenarios. Importantly, this review goes over the current understanding of the pathophysiology and clinical practice experience for pregnant patients with VTE. We also explored the variation in professional clinical guidelines on VTE prophylaxis and treatment strategies in pregnancy, and how these guidelines may be interpreted in the context of patient care for optimal outcomes.
Related
- How we treat venous thromboembolism in pregnancy in a resource‐limited setting
- Recurrent venous thromboembolism despite natural cycle frozen embryo transfer in a woman with a history of pregnancy-related venous thromboembolism: A case report.
- Standardized Tool for Prophylaxis (SToP) of venous thromboembolism: An asynchronous curriculum to enhance venous thromboembolism prevention in pediatric inflammatory bowel disease.
- CO090 | DIRECT ORAL ANTICOAGULANTS IN THE SECONDARY PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE INHERITED THROMBOPHILIA: A REAL-WORLD MULTICENTER STUDY
- Knowledge, attitudes, and practices regarding venous thromboembolism prevention in patients with lung cancer
BibTeX
@article{nwachukwu2026venous,
title = {{Venous Thromboembolism and Pregnancy: Prevention and Treatment}},
author = {Nneka Nwachukwu and Manila Gaddh},
journal = {Journal of Clinical Medicine},
year = {2026},
month = nov,
doi = {10.3390/jcm15218546},
url = {https://www.mdpi.com/2077-0383/15/21/8546},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Venous Thromboembolism and Pregnancy: Prevention and Treatment
AU - Nneka Nwachukwu
AU - Manila Gaddh
PY - 2026
DA - 2026/11/03
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218546
UR - https://www.mdpi.com/2077-0383/15/21/8546
AB - Pregnancy-related venous thromboembolism (VTE) remains a leading cause of maternal morbidity and mortality. Physiologic changes in pregnancy, along with patient-specific and pregnancy-specific risk factors, increase this VTE risk. The prevention and treatment of pregnancy-related VTE is often complex and requires the careful consideration of variation in clinical guidelines, VTE risk profile, bleeding assessment, careful delivery planning and patient preference. The mainstay of treatment for an acute VTE in pregnancy is the use of low-molecular-weight heparin. In this review, we highlight three clinical cases to review clinical approaches to the prevention and treatment of VTE in pregnancy in these scenarios. Importantly, this review goes over the current understanding of the pathophysiology and clinical practice experience for pregnant patients with VTE. We also explored the variation in professional clinical guidelines on VTE prophylaxis and treatment strategies in pregnancy, and how these guidelines may be interpreted in the context of patient care for optimal outcomes.
SN - 2077-0383
ER -